Enveric Biosciences (ENVB) CFO awarded 133,333 RSUs in long-term equity grant
Rhea-AI Filing Summary
Coveney Kevin Michael reported acquisition or exercise transactions in this Form 4 filing.
Enveric Biosciences, Inc. reported that Chief Financial Officer Kevin Michael Coveney received a grant of 133,333 restricted stock units under the company’s 2020 Long-Term Incentive Plan. These RSUs are a form of equity compensation and were granted at no cash cost per unit.
For each vested RSU, Coveney will receive one share of common stock, bringing his total reported direct holdings to 180,746 shares after the grant. One-fourth of the RSUs will vest on the one-year anniversary of the grant date, then one‑thirty‑sixth will vest each month, with any remaining RSUs vesting on the fourth anniversary, all conditioned on continued employment.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 133,333 shares
Net Buy
1 txn
Insider
Coveney Kevin Michael
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 133,333 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 180,746 shares (Direct)
Footnotes (1)
- F1. Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance. An additional one-thirty-sixth of the RSUs will vest each month following the first vesting date. Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company.
Key Figures
RSUs granted: 133,333 units
Price per RSU: $0.0000 per unit
Shares after transaction: 180,746 shares
+3 more
6 metrics
RSUs granted
133,333 units
Restricted stock units granted to CFO on 2026-06-01
Price per RSU
$0.0000 per unit
Grant price for restricted stock units
Shares after transaction
180,746 shares
Total common stock beneficially owned following grant
Initial vesting portion
One-fourth of RSUs
Vests on one-year anniversary of grant date
Ongoing vesting schedule
One-thirty-sixth monthly
Vests each month after first vesting date
Final vesting date
Fourth anniversary
Any remaining RSUs vest on fourth anniversary of issuance
Key Terms
restricted stock units, 2020 Long-Term Incentive Plan, vesting, continued employment
4 terms
restricted stock units financial
"Represents the restricted stock units (the "RSUs") granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2020 Long-Term Incentive Plan financial
"granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan, as amended"
vesting financial
"One-fourth of the RSUs will vest upon the one-year anniversary of the date of issuance"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continued employment financial
"Any remaining RSUs will vest on the fourth anniversary of the date of issuance. Vesting is conditioned upon continued employment by the Company."
Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Enveric Biosciences (ENVB) report for its CFO?
Enveric Biosciences reported that CFO Kevin Michael Coveney received 133,333 restricted stock units as equity compensation. The grant, at no cash cost per unit, increases his direct holdings to 180,746 shares, aligning his compensation partly with the company’s stock performance over time.
How many Enveric Biosciences (ENVB) RSUs were granted to the CFO?
The CFO received a grant of 133,333 restricted stock units from Enveric Biosciences. Each RSU converts into one share of common stock as it vests, providing long-term equity-based compensation that vests over several years, subject to the executive’s continued employment with the company.
What is the vesting schedule for the Enveric Biosciences (ENVB) CFO’s RSUs?
One-fourth of the CFO’s RSUs will vest on the one-year anniversary of the grant date. After that, one‑thirty‑sixth of the RSUs will vest monthly, and any remaining RSUs will vest on the fourth anniversary, all contingent on continued employment at Enveric Biosciences.
Did the Enveric Biosciences (ENVB) CFO pay for the newly granted RSUs?
The Form 4 shows a transaction price per share of $0.0000 for the CFO’s RSU grant. This indicates the restricted stock units were awarded as compensation rather than purchased in the open market, consistent with typical long-term incentive plan structures for executives.